Phase I Study of Vorinostat in Combination with Decitabine in Patients with Relapsed or Newly Diagnosed Acute Myelogenous Leukemia or Myelodysplastic Syndrome

被引：0
|
作者：
Kirschbaum, Mark [1 ]
Gojo, Ivana [2 ]
Goldberg, Stuart L. [3 ]
Kujawski, Lisa [4 ]
Atallah, Ehab [5 ]
Marks, Peter [6 ]
Garcia-Vargas, Jose [7 ]
Rizvi, Syed [7 ]
Di Gravio, Donna [7 ]
Ahern, Janet [7 ]
Issa, Jean-Pierre [8 ]
机构：
[1] City Hope Natl Med Ctr, Duarte, CA 91010 USA
[2] Univ Maryland, Med Ctr, Baltimore, MD 21201 USA
[3] Hackensack Univ, Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USA
[4] Univ Michigan, Ann Arbor, MI 48109 USA
[5] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[6] Yale Univ, Sch Med, New Haven, CT USA
[7] Merck & Co Inc, Upper Gwynedd, PA USA
[8] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1250 / 1250
页数：1
相关论文
共 50 条
  • [21] A therapeutic trial of decitabine and vorinostat in combination with chemotherapy for relapsed/refractory acute lymphoblastic leukemia
    Burke, Michael J.
    Lamba, Jatinder K.
    Pounds, Stanley
    Cao, Xueyuan
    Ghodke-Puranik, Yogita
    Lindgren, Bruce R.
    Weigel, Brenda J.
    Verneris, Michael R.
    Miller, Jeffrey S.
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (09) : 889 - 895
  • [22] Phase I trial of plerixafor combined with decitabine in newly diagnosed older patients with acute myeloid leukemia
    Roboz, Gail J.
    Ritchie, Ellen K.
    Dault, Yulia
    Lam, Linda
    Marshall, Danielle C.
    Cruz, Nicole M.
    Hsu, Hsiao-Ting C.
    Hassane, Duane C.
    Christos, Paul J.
    Ippoliti, Cindy
    Scandura, Joseph M.
    Guzman, Monica L.
    HAEMATOLOGICA, 2018, 103 (08) : 1308 - 1316
  • [23] A phase I pharmacolkinetic trial of decitabine administered as a 3-hour infusion to patients with acute myelogenous leukemia (AML) or myelodysplastic syndrome (MDS).
    Cashen, A
    Shah, A
    Helget, A
    Todt, L
    Fisher, N
    DiPersio, J
    BLOOD, 2005, 106 (11) : 527A - 528A
  • [24] Gemtuzumab ozogamicin in combination with vorinostat and azacitidine in older patients with relapsed or refractory acute myeloid leukemia: a phase I/II study
    Walter, Roland B.
    Medeiros, Bruno C.
    Gardner, Kelda M.
    Orlowski, Kaysey F.
    Gallegos, Leonel
    Scott, Bart L.
    Hendrie, Paul C.
    Estey, Elihu H.
    HAEMATOLOGICA, 2014, 99 (01) : 54 - 59
  • [25] Phase I/II study of sapacitabine and decitabine administered sequentially in elderly patients with newly diagnosed acute myeloid leukemia.
    Ravandi, F.
    Faderl, S.
    Cortes, J. E.
    Garcia-Manero, G.
    Jabbour, E.
    Boone, P. A.
    Kadia, T. M.
    Borthakur, G.
    Wierda, W. G.
    Chiao, J. H.
    Kantarjian, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [26] Results of Phase 2 Randomized Study of Low-Dose Decitabine With or Without Valproic Acid in Patients With Myelodysplastic Syndrome and Acute Myelogenous Leukemia
    Issa, Jean-Pierre
    Garcia-Manero, Guillermo
    Huang, Xuelin
    Cortes, Jorge
    Ravandi, Farhad
    Jabbour, Elias
    Borthakur, Gautam
    Brandt, Mark
    Pierce, Sherry
    Kantarjian, Hagop M.
    CANCER, 2015, 121 (04) : 556 - 561
  • [27] Phase II Study of 5-Azacitidine and Vorinostat In Patients (pts) with Newly Diagnosed Myelodysplastic Syndrome (MDS) or Acute Myelogenous Leukemia (AML) Not Eligible for Clinical Trials Because Poor Performance or Presence of Other comorbidities
    Garcia-Manero, Guillermo
    Estey, Elihu H.
    Jabbour, Elias
    Kadia, Tapan
    Estrov, Zeev
    Cortes, Jorge
    Boone, Patricia Ann
    Kantarjian, Hagop M.
    BLOOD, 2010, 116 (21) : 266 - 266
  • [28] Decitabine and Vorinostat with Chemotherapy in Relapsed Pediatric Acute Lymphoblastic Leukemia: A TACL Pilot Study
    Burke, Michael J.
    Kostadinov, Rumen
    Sposto, Richard
    Gore, Lia
    Kelley, Shannon M.
    Rabik, Cara
    Trepel, Jane B.
    Lee, Min-Jung
    Yuno, Akira
    Lee, Seonju
    Bhojwani, Deepa
    Jeha, Sima
    Chang, Bill H.
    Sulis, Maria Luisa
    Hermiston, Michelle L.
    Gaynon, Paul
    Van Huynh
    Verma, Anupam
    Gardner, Rebecca
    Heym, Kenneth M.
    Dennis, Robyn M.
    Ziegler, David S.
    Laetsch, Theodore W.
    Oesterheld, Javier E.
    Dubois, Steven G.
    Pollard, Jessica A.
    Glade-Bender, Julia
    Cooper, Todd M.
    Kaplan, Joel A.
    Farooqi, Midhat S.
    Yoo, Byunggil
    Guest, Erin
    Wayne, Alan S.
    Brown, Patrick A.
    CLINICAL CANCER RESEARCH, 2020, 26 (10) : 2297 - 2307
  • [29] Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia and High-Risk Myelodysplastic Syndrome
    Daver, Naval
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    Estrov, Zeev
    Konopleva, Marina
    Burger, Jan A.
    O'Brien, Susan
    Ferrajoli, Alessandra
    Verstovsek, Srdan
    Kadia, Tapan M.
    Jabbour, Elias J.
    Faderl, Stefan
    Diaz-Pines-Mateo, Maria
    Pemmaraju, Naveen
    Pierce, Sherry A.
    Cortes, Jorge E.
    Borthakur, Gautam
    BLOOD, 2012, 120 (21)
  • [30] Results of a Phase I Open-Label Study of Decitabine in Combination with Midostaurin (PKC412) for Elderly (Age ≥ 60) Newly Diagnosed or Relapsed/Refractory Adult Patients with Acute Myeloid Leukemia
    Williams, Casey B.
    Kambhampati, Suman
    Ganguly, Siddhartha
    Aljitawi, Omar S.
    Reyes, Ruben
    Fleming, Allan
    Bhalla, Kapil N.
    Abhyankar, Sunil
    McGuirk, Joseph
    BLOOD, 2011, 118 (21) : 1542 - 1542
12345